Genzyme Europe B.V. | diagnosia.com

Genzyme Europe B.V.

Address: -
Telephone: -
Fax: -
Web: -
Email: -
Corporate Phone: -

For Pharmacy Companies

Get your Diagnosia.com profile and a presence on europe's leading medical drug search.

Logo Upload your logo
Contact details Your full contact details
Branding Let your CI do the talking
Newsfeed Integrate your corporate news

More Information

Drugs produced by Genzyme Europe B.V.

Aldurazyme 100 U/ml concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: A16AB05
Cerezyme 200 U Powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: A16AB02
- Therapeutic Area: Gaucher Disease
- Active Substance: Imiglucerase
Cerezyme 400 U Powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: A16AB02
- Therapeutic Area: Gaucher Disease
- Active Substance: Imiglucerase
Cholestagel 625 mg film-coated tablets
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: C10AC04
- Therapeutic Area: Hypercholesterolemia
- Active Substance: Hydrochloride
Evoltra 1 mg/ml concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: L01BB06
- Active Substance: Clofarabine
Fabrazyme 35 mg, powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: A16AB04
- Therapeutic Area: Fabry Disease
- Active Substance: Agalsidase Beta
Fabrazyme 5 mg, powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: A16AB04
- Therapeutic Area: Fabry Disease
- Active Substance: Agalsidase Beta
MabCampath 10 mg/ml concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: L01XC04
- Therapeutic Area: Leukemia
- Active Substance: Alemtuzumab
MabCampath 30 mg/ml concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: L01XC04
- Therapeutic Area: Leukemia
- Active Substance: Alemtuzumab
Mozobil 20 mg/ml solution for injection
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: L03AX16
- Therapeutic Area: Multiple Myeloma, Lymphoma
- Active Substance: Plerixafor
Myozyme 50 mg powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: A16AB07
Renagel 400 mg film-coated tablets
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: V03AE02
- Active Substance: Sevelamer, Hydrochloride
Renagel 800 mg film-coated tablets
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: V03AE02
- Active Substance: Sevelamer, Hydrochloride
Renvela 1.6 g powder for oral suspension
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: V03AE02
- Active Substance: Sevelamer Carbonate, Sevelamer
Renvela 2.4 g powder for oral suspension
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: V03AE02
- Active Substance: Sevelamer Carbonate, Sevelamer
Renvela 800 mg film-coated tablets
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: V03AE02
- Active Substance: Sevelamer Carbonate, Sevelamer
Thyrogen 0.9 mg powder for solution for injection
- admission:
  Great Britain
- Producer: Genzyme Europe B.V.
- ATC-Code: H01AB01